期刊文献+

高血压MMP-9基因多态性与心脏及血管重构的关系 被引量:1

Relationship between matrix metalloproteinases-9 gene polymorphism and the cardiovascular remodeling in hypertension patients
原文传递
导出
摘要 目的研究基质金属蛋白酶基因多态性与高血压患者心脏及血管重构的关系。方法高血压患者53例,健康对照组30例。采用心脏彩色多普勒超声检测左心室舒张末期室间隔厚度(IVSTd)、舒张末期左心室后壁厚度(LVPWTd)、颈动脉内膜中层厚度(IMT)。测量患者上下肢血压并计算踝臂指数(ABI)。采用多聚酶链式反应结合限制性内切酶法检测基质金属蛋白酶-9(MMP-9)基因的C-1562T基因多态性。结果 MMP-9基因的C-1562T多态性与高血压的发生发展无相关性(P>0.05);携带T等位基因的高血压人群的IVSTd、LVPWTd和颈动脉IMT较不携带T等位基因高血压人群明显增厚(P<0.05);携带T等位基因的高血压人群均较不携带T等位基因高血压人群的ABI低;高血压患者的C-1562T基因多态性与IVSTd、LVPWTd和颈动脉IMT呈正相关(P<0.05),与ABI呈显著负相关(P<0.05),高血压患者年龄愈高其ABI愈小。结论 MMP-9的TC基因型是影响高血压患者心脑及血管重构的重要因素之一。 Objective To explore the relationship between matrix metalloproteinases-9 gene polymorphism and the cardiovascular remodeling in hypertension patients. Methods 53 hypertension patients were randomly selected. 30 healthy people were selected as the control group. Ventricular end-diastolic interventricular septum (IVSTd), end-diastolic left ventricular wall thickness(LVPWTd) and carotid intima media thikness(IMT) were determined by Doppler ultrasonography. The blood pressure of upper and lower limbs was measured and the ABI was calculated. The C-1562T gene polymorphism of MMP-9 was measured by polymerase chain reaction combined with restriction enzyme digestion. Results MMP-9 gene polymorphism was not associated with the onset and development of hypertension ( P 〉 0.05 ) ; IVSTd, LVPWTd and IMT of hypertension patients who carried the T alleles was thicker than that of the hypertension patientswho didn't carry the T alleles(P 〈0.05) ;ABI of hypertension patieints who carried the T alleles was lower than that of the patients who didn' t carry the T alleles;The C-1562T gene polymorphism of the hypertension patients was positively correlated with the IVSTd, LVPWTd and IMT( P 〈 0.05 ), and was negatively correlated with the ABI( P 〈 0.05 ). Age had negative correlations with the ABI in the hypertension patients. Conclusion C-1562T gene polymorphism of MMP-9 gene is one of the important factors that effect the cardiovascular remodeling in the hypertension patients.
出处 《山东大学学报(医学版)》 CAS 北大核心 2013年第2期61-64,共4页 Journal of Shandong University:Health Sciences
关键词 基因多态性 基质金属蛋白酶-9 心室舒张末期室间隔厚度 舒张末期左心室后壁厚度 动脉内膜中层厚度 左心室质量指数 高血压 踝臂指数 心室重构 Gene polymorphism Matrix metalloproteinases-9 ventricular end-diastolic interventricular septum thick-ness(IVSTd) End-diastolic left ventricular wall thickness(LVPWTd) Carotid intima media thikness (IMT) Hyper-tension Ankle brachial index(ABI) Cardiovascular remodeling
  • 相关文献

参考文献4

二级参考文献39

  • 1张雪梅,缪小平,熊萍,于春媛,谭文,曲世宁,孙瞳,周翊峰,林东昕.基质金属蛋白酶(MMP)-2和-9功能性单核苷酸多态与胃癌[J].癌症,2004,23(11):1233-1237. 被引量:9
  • 2温绍君,王佐广,陈光慧,刘雅,刘洁琳,罗毅,汤健.HSG基因单核苷酸多态性与原发性高血压的相关性研究[J].中华预防医学杂志,2005,39(1):15-18. 被引量:19
  • 3Johnson GC, Todd JA. Strategies in complex disease mapping. Curr Opin Genet Dev, 2000, 10: 330-334.
  • 4Zervoudaki A, Economou E, Stefanadis C, et al.Plasma levels of active extracellular matrix metallo proteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment. J Hum Hypertens, 2003, 17 : 119-124.
  • 5Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hyper tens, 2003, 21: 1983-1992.
  • 6Zhang R, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinanse B gerie in relation to severity of coronary atherosclerosis. Circulation, 1999, 99:1788-1794.
  • 7Montaner J, Fernandez-Cadenas I, Molina CA, et al. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene. Stroke, 2003, 34:2851-2855.
  • 8Zhang B, Dhillon S, Geary I, et al. Polymorphisms in matrix metalloproteinases -1, -3, -9 and-12 genes in relation to subarachnoid hemorrhage. Stroke, 2001, 32: 2198-2202.
  • 9Li-Saw-Hee FL, Edmunds E, Blann AD, et al. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. Int J Cardiol, 2000, 75: 43-47.
  • 10Tayebjee MH, Nadar S, Blann AD, et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am J Hypertens, 2004, 17: 764-769.

共引文献23

同被引文献16

  • 1Vendecchia P,Schillaci G,Borgioni C.Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass[J] .J Am Coll Cardiol,1995,25(4):871-878.
  • 2Heymans S,Schroen B,Vermeersch P,et al.Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart[J].Circulation,2005,112(8)&#x02236;1136-1144.
  • 3Ahmed SH,Clark LL,Pennington WR,et al.Matrix metalloproteinases tissue inhibitors of metalloproteinases:relationship between changes in proteolytic determinants of matrix composition and Structural,functional,and clinical manifestations of hypertensive heart disease[J].Circulation,2006,113( 17):2089-2096.
  • 4Zile MR,Brutsaert DL.New concepts in diastolic dysfunction and diastolic heart failure:Part l:diagnosis,prognosis,and measurements of diastolic function[J].Circulation,2002,105(11):1387-1393.
  • 5Lemarie CA,Tharaux PL,Lehoux S.Extracellular matrix alterations in hypertensive vascular remodeling [J].J Mol Cell Cardiol,2010,48(3):433-439.
  • 6Castro MM,Tanus -Santos JE,Gerlach RF .Matrix metalloproteinases targets for doxycycline to prevent the vascular alterations of hypertension[J].Pharmacol Res,2011,64(6):567-572.
  • 7Onal IK,Altun B,Onal ED,et al.Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment[J].Eur J Intern Med,2009,20(4):369-372.
  • 8Rosenberg GA,Cunningham LA,Wallace J,et al.Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain:activation of MMP-9 linked to stromelysin-1 and microglia in cells cultures [J].Brain Res,2001,893(122):104-112.
  • 9Zile MR,DeSantis SM,Baicu CF,et al.Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure[J].Circ Heart Fail,2011,4(3):246-256.
  • 10Saglam M,Karakaya O,Esen A M,et al.Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects[J].Tohoku J Exp Med,2006,208(2):117-122.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部